Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Finished Goods (2024 - 2026)

Mesoblast's (MEOBF) quarterly Finished Goods came in at $6.6 million in Q2 2026, down 68.74% year-over-year from $21.2 million in Q2 2025, and down 57.43% quarter-over-quarter from $15.6 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Finished Goods (2024 - 2026) Analysis & Trends

Mesoblast has disclosed Finished Goods across 3 years of filings, most recently posting $6.6 million for Q2 2026.

  • In Q2 2026, Finished Goods fell 68.74% year-over-year to $6.6 million; the TTM figure through Jun 2026 stood at $6.6 million (down 68.74% YoY), while the FY2026 annual figure was $6.6 million, down 68.74% from the prior year.
  • Finished Goods came in at $6.6 million for Q2 2026 at Mesoblast, down from $15.6 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $23.2 million in Q4 2024 to a low of $6.6 million in Q2 2026.
  • Average Finished Goods over 3 years is $16.7 million, with a median of $18.4 million recorded in 2025.
  • Year-over-year, Finished Goods slumped 33.1% in 2025 and slumped 68.74% in 2026.
  • Over 3 years, Finished Goods stood at $23.2 million in 2024, then tumbled by 33.1% to $15.6 million in 2025, then tumbled by 57.43% to $6.6 million in 2026.
  • Per Business Quant data, the three most recent Finished Goods figures were $6.6 million in Q2 2026, $15.6 million in Q4 2025, and $21.2 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.62 Mn
Dec 31, 2025 15.55 Mn
Jun 30, 2025 21.18 Mn
Dec 31, 2024 23.25 Mn